Bacil Pharma Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported revenue was INR 0.157 million compared to INR 0.351 million a year ago. Net loss was INR 0.22 million compared to INR 0.323 million a year ago. Basic loss per share from continuing operations was INR 0.04 compared to INR 0.05 a year ago. Diluted loss per share from continuing operations was INR 0.04 compared to INR 0.05 a year ago.
For the nine months, revenue was INR 0.492 million compared to INR 0.758 million a year ago. Net loss was INR 1.23 million compared to INR 0.454 million a year ago. Basic loss per share from continuing operations was INR 0.21 compared to INR 0.08 a year ago. Diluted loss per share from continuing operations was INR 0.21 compared to INR 0.08 a year ago.